Spyre Therapeutics SYRE
NASDAQ SYRE
$89.03 +4.31 (+5.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Receivables (2021 - 2024)

Updated

Spyre Therapeutics (SYRE) recorded Receivables of $5.9 million in Q4 2024, unchanged from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Receivables (2021 - 2024) Analysis & Trends

Starting with Q1 2021, Spyre Therapeutics' Receivables history includes 4 quarters.

  • Quarterly Receivables has ranged from $5.9 million in Q2 2024 to $21.5 million in Q1 2021 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 19.05 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 13.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.68 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.13 Bn
10 Spyre Therapeutics 7.46 Bn 7.46 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5.90 Mn
Sep 30, 2024 5.90 Mn
Jun 30, 2024 5.90 Mn
Mar 31, 2021 21.50 Mn
API Access

Spyre Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=SYRE&period=max&api_key=YOUR_API_KEY